Stock & Company Details
Acumen Pharmaceuticals Inc $ABOS
Price:
N/A
N/A
72M
$14M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.12
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABOS technical indicators
Latest Acumen Pharmaceuticals Inc (ABOS) indicator readings as of 2026-11-19.
ABOS's 14-day RSI is 21.9, in oversold territory. ADX reads 43.6, indicating a trending market. MACD (12, 26, 9) is -0.46, below the zero line.
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believe to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
Finance Bot
Ask your questions
Start by typing a question below.